Flow Traders U.S.’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.7M Buy
+60,268
New +$7.52M 0.24% 75
2025
Q3
Sell
-2,801
Closed -$232K 1288
2025
Q2
$232K Sell
2,801
-9,734
-78% -$777K 0.01% 812
2025
Q1
$1.02M Buy
+12,535
New +$1.12M 0.04% 394
2024
Q2
Sell
-17,792
Closed -$1.69M 1110
2024
Q1
$1.69M Buy
17,792
+11,834
+199% +$1.1M 0.09% 208
2023
Q4
$532K Buy
+5,958
New +$442K 0.02% 484
2023
Q2
Sell
-36,927
Closed -$2.81M 1125
2023
Q1
$2.81M Buy
+36,927
New +$3.06M 0.11% 134
2021
Q3
Sell
-4,907
Closed -$664K 1194
2021
Q2
$664K Buy
+4,907
New +$645K 0.03% 512
2020
Q4
Sell
-17,769
Closed -$1.98M 797
2020
Q3
$1.98M Sell
17,769
-3,800
-18% -$426K 0.15% 143
2020
Q2
$2.42M Buy
+21,569
New +$2.12M 0.19% 103
2017
Q2
Sell
-7,260
Closed -$503K 358
2017
Q1
$503K Buy
7,260
+269
+4% +$18.1K 0.04% 206
2016
Q4
$414K Buy
+6,991
New +$432K 0.03% 226
2016
Q3
Sell
-4,132
Closed -$223K 476
2016
Q2
$223K Sell
4,132
-100,452
-96% -$5.5M 0.02% 173
2016
Q1
$5.4M Buy
+104,584
New +$5.43M 0.55% 41
2014
Q3
Sell
-6
Closed 225
2014
Q2
$0 Buy
+6
New +$271 ﹤0.01% 240

Other funds holding XBI

Flow Traders U.S.'s XBI Position: Q1 2026 in Review

Flow Traders U.S. opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 60,268 shares worth $7.7M. The stake represents 0.24% of the portfolio and ranks #75 among its holdings. This is a return to the name: Flow Traders U.S. previously reported a position in XBI as recently as Q2 2025.

Flow Traders U.S. first reported a position in XBI in Q2 2014 and has held it in 14 quarters since. 815 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Flow Traders U.S. held 60,268 shares of State Street SPDR S&P Biotech ETF worth $7.7M as of Q1 2026.
  • State Street SPDR S&P Biotech ETF was a new Flow Traders U.S. position in Q1 2026.
  • State Street SPDR S&P Biotech ETF made up 0.24% of Flow Traders U.S.'s portfolio in Q1 2026, its #75 holding.
  • Flow Traders U.S. first reported a position in State Street SPDR S&P Biotech ETF in Q2 2014 and has held it in 14 quarters since.
  • 815 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Flow Traders U.S.'s 13F filing for Q1 2026, filed 15 May 2026.